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This newsletter was jointly developed 
by the Department of Health Policy at 
Jefferson Medical College and Eli Lilly 
and Company and is supported through 
funding by Eli Lilly and Company.
Welcome to the premiere issue of 
Prescriptions for Excellence in Health 
Care, a series of supplements to our 
Health Policy Newsletter devoted to 
the quality improvement agenda. 
Change - in regulations, technology, 
and quality measurement, to name 
a few - is accelerating exponentially. 
Amid this constant change, it 
is challenging for health care 
professionals to remain current on 
the programs and initiatives being 
implemented. To help address this 
issue, the Department of Health 
Policy has partnered with Eli 
Lilly and Company to provide 
you with essential information 
from the quality improvement 
and patient safety arenas. 
Improving the quality of health care 
in America has been the focus of 
policy debates since the Institute 
of Medicine (IOM) published its 
groundbreaking study, Crossing the 
Quality Chasm.  Most of the first 
decade of the 21st century has 
been spent deliberating how best to 
measure, monitor, and manage health 
care delivery to ensure that patients 
receive the type of care they have a 
right to expect in the world’s richest 
nation.  While the intent to provide 
safe, scientifically validated treatment 
has never been in doubt, there 
definitely is room for improvement 
in the execution of these efforts.
The IOM specified that the 
“right” or high-quality health care 
is safe, effective, timely, efficient, 
evidence-based, and equitable.  
Driving our health care system to 
the point of consistently getting 
these “right things” right will not 
only help to optimize outcomes, 
it also will reduce costs.  
Government, payors, and providers 
have been working diligently 
to develop appropriate systems, 
incentives, and reporting mechanisms 
that will assist providers to 
optimize quality and reduce costs, 
and empower patients to make 
informed choices regarding their 
care.  Beginning in 2008, the Centers 
for Medicare and Medicaid Services 
(CMS) will no longer pay for the 
consequences of medical errors.  
Hospitals will have to absorb the 
costs of flawed processes and delivery 
systems that result in “never” events 
such as wrong-site surgery and 
hospital-acquired infection. Forward-
thinking leaders in an increasing
(continued on page 2)
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At Eli Lilly and Company, we 
understand that we have an 
important role in the transformation 
of the health care industry.  We 
are committed to effecting positive 
change via continued partnerships 
with other stakeholders to enhance 
the health care delivery process and 
maximize value through improved 
outcomes for each patient.  
The pace of change in health care is 
accelerating, and a new health care 
system is evolving that will balance 
cost, quality, access, and innovation 
by leveraging price/quality 
transparency, and will use more 
health information technology to 
deliver value-based care.  To meet the 
demands of this market, we at Lilly 
challenge ourselves to reevaluate 
our processes at every level, seeking 
to consistently transform how we 
do business so that we align with 
the needs of our customers and the 
marketplace.  By doing so, we strive 
to continue delivering value through 
innovation and partnerships.  
Greater transparency, accountability, 
value, and efficiency will 
characterize the emerging health 
care system – qualities that are 
necessary to provide health 
care in the face of the greatest 
demographic shift the United 
States and the world have ever 
seen.  While the degree of change 
required is daunting, collectively 
we are making progress.  
I believe that we will be successful 
in our efforts to help create a health 
care system for this country that 
will be the envy of the world–a 
system based on innovation, choice, 
and competition that enables the 
betterment of the lives of its citizens.  
It will not be easy.  It will require 
hard choices, tough trade-offs, and 
disciplined implementation, but few 
things could be more important than 
creating a company and a health care 
system worthy of the next generation.   
The credo of our founder, Colonel 
Eli Lilly, was: “Take what you find 
here and make it better.”  We remain 
steadfast in our commitment to 
improve US health care delivery.  I am 
confident that we will succeed in our 
collaboration to shape the evolution 
of the health care system and look 
forward to our role in this journey.
Jack Bailey is Vice President, Business 
to Business, at Eli Lilly and Company.
Collaboration to Create a Better Health Care System
By Jack Bailey
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number of states are requiring public 
reporting of a variety of quality 
measures that will enable patients to 
make more informed decisions about 
whether and where to have elective 
surgery, and even to compare costs.
These efforts align with CMS’ 
Quality Improvement Roadmap, 
which was outlined in detail 
in a previous editorial.1
Progress will begin on several of the 
strategies outlined in the roadmap in 
the coming months, namely:  creating 
partnerships to improve performance; 
applying useful measures of quality 
of care (eg, outcomes, consumer 
experience, cost of care); and 
implementing a payment schedule 
that focuses on quality of patient 
care rather than services received.
In March 2007, the Department 
of Health Policy convened a 
diverse panel of national health 
care thought leaders to discuss the 
most recent efforts in performance 
improvement, public reporting, 
patient safety, and health 
information technology.  Panelists 
will contribute articles to this 
supplement series that reflect their 
experiences and areas of expertise.
Among the offerings in this 
inaugural issue are a general 
overview of the national quality 
landscape; a discussion of the role 
of regional quality improvement 
organizations (QIOs); a review of 
an innovative leadership training 
program in patient safety; and a 
report detailing Pennsylvania’s 
efforts in public reporting on 
hospital quality.  Future issues will 
provide insight on such issues as 
hospital quality improvement efforts, 
improving the quality of care in 
outpatient settings, and the role of 
health information technology and 
public reporting.  I am extremely 
proud of the wealth of information 
presented by our awesome initial 
group of authors, and hope you 
will find it enlightening.  As 
always, I am interested in your 
feedback; you can reach me by 
email at david.nash@jefferson.edu. 
David B. Nash, MD, MBA is the  
Dr. Raymond C. and Doris N. 
Grandon Professor of Health Policy, 
and Chairman, Department of 
Health Policy at Jefferson Medical 
College. He can be reached at 
david.nash@jefferson.edu.
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Confident predictions about the 
future of health care are notoriously 
unreliable, be it the surefire status of 
single-payer (c.1973) or the unstoppable 
march of “managed competition” 
(c. 1993).  Yet, while the noisy 50-
year war over the design of the ideal 
health insurance system continues to 
command headlines, a quiet consensus 
has developed that is beginning to 
shape the future of actual patient care. 
When compared to even 5 years ago, the 
expectations of payors, government, and 
the general public about what providers 
should be doing and how they should 
be held accountable for doing it have 
changed significantly. Legislatures and 
oversight organizations are adding new 
requirements related to safety, evidence-
based care, and transparency on a regular 
basis. Old standards are being toughened. 
The pace of change is increasing. 
What gives the current situation the 
potential to be transformational rather 
than transitional?  Three powerful forces 
are converging to undermine what was 
previously a cottage industry and reshape 
it into a high-quality, cost-effective, 
care delivery system. These forces are:
•	 Economics. For the first 
 time, the economic inefficiency 
 of American health care is 
 being defined as a problem 
 affecting both our economic 
 and national security, according 
 to Comptroller General David 
 Walker. That assessment by the
 head of Congress’ United States 
 Government Accountability 
 Office has drawn support 
 from the public and private 
 sectors, from all points on the 
 political spectrum, and from 
 the American Association 
 of Retired Persons (AARP).
•	 Technology. The slow adoption 
 of information technology (IT) 
 by health care providers, a 
 high-visibility failing, is being 
 tracked by employers, 
 health plans, and government. 
 Meanwhile, health plans and 
 government agencies have  
 begun routinely using IT to 
 identify hospitals and physicians 
 who fall short of quality and 
 cost standards. 
•	 Zeitgeist. The “spirit of the 
 times” is exemplified by 
 increasing public intolerance 
 for unsafe and unnecessary care. 
 Whether it be large corporations 
 refusing to pay hospitals for 
 “never events” (ie, egregious
 medical errors, such as wrong-
 site surgery, which should 
 never occur), or The Onion 
 satirizing doctors for not 
 washing their hands, the 
 spotlight on costly care 
 deficiencies has become 
 impossible to avoid.
A series of statistics illustrates why 
out-of-control health care costs are 
being scrutinized. Health care was the 
nation’s greatest tax expenditure in 
2005, and the growth of health care 
costs (Medicare and Medicaid), along 
with Social Security, far outpaces overall 
economic growth at a time of deep 
and worrisome federal budget deficits.1 
According to a Boston University 
study,2 if the growth in health care 
expenditures from fiscal 2000 to 2005 
had been limited to the same rate as the 
overall US economy, the savings would 
have totaled $1 trillion – an amount 
roughly equivalent to the entire US 
defense budget in fiscal 2005, plus the 
total spent by all levels of government 
on elementary and secondary education. 
This is the framework within which 
arguments over “pay for performance” 
must be viewed. At present, incentives 
are modest. For example, the employer-
sponsored Bridges to Excellence 
program rewards physicians who 
provide evidence-based diabetes care 
with a small financial payment and a 
public listing of their names. If these 
voluntary provider incentives fail to 
prompt significant improvements, 
however, the only alternative is bigger 
incentives and stiffer penalties from 
payors.  Moreover, as with Bridges, the 
accountability will be provider-specific.
Unlike the managed competition 
movement of the mid-1990s, the effort 
to press providers for higher-quality, 
more cost-effective care is likely to enjoy 
broad public support. As Kaiser Family 
Foundation 2006 data show, premiums 
for employer-sponsored health insurance 
in the United States have been rising 
significantly faster on average than 
workers’ earnings since 2001, although 
the pace has recently slowed.3 Even 
among larger companies, the percentage 
of employees who can afford to pay their 
share of those benefits is declining. 
Just as importantly, the new demands 
for accountability are seen as both 
justified and achievable. The medical 
literature regularly reveals new examples 
of inefficiency. One oft-cited  study is 
Elliott Fisher and colleagues’ research 
concluding that high-spending 
Medicare regions have the same 
or lower technical quality, health 
outcomes, and physician and patient
(continued on page 4)
The Cottage Industry Crumbles:
QI and the Foundations of Health Care
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satisfaction than lower-spending 
regions, while consuming up to 60% 
more resources.4,5 The next step is to 
apply similar measures to individual 
hospitals and publish the results. 
The CMS/Premier Hospital Quality 
Incentive Demonstration (HQID), 
involving more than 260 hospitals, 
translated quality improvement research 
theory into practice. HQID showed 
measurable success in improving care 
quality in 5 clinical areas, saving a 
startling 1,284 lives from heart attacks 
alone. According to Premier’s analysis, 
if all pneumonia, heart bypass, heart 
attack (acute myocardial infarction), 
and hip and knee replacement patients 
nationally received most or all (76% 
to 100%) of a set of widely accepted 
care processes in 2004, it could have 
resulted in nearly 5,700 fewer deaths, 
8,100 fewer complications, 10,000 fewer 
readmissions, and 750,000 fewer hospital 
days. In addition, hospital costs could 
have been as much as $1.35 billion lower.
Health IT alone does not improve 
care, but it is a critical tool for 
doing so, particularly in the area of 
patient safety. Especially in large, 
complex organizations, focused use 
of IT is essential for measuring and 
managing care to consistently achieve 
high-performance results. More 
pragmatically, payors and government 
are using sophisticated databases to 
hold hospitals, physician groups, and 
even individual physicians accountable 
for meeting certain care standards. 
Analytic computer technology plus 
Internet dissemination technology 
has made it possible to identify high 
performers (either in outcomes or 
in adherence to evidence-based 
practices) for specific procedures, 
specific hospitals, and specific 
physicians. Patient satisfaction data 
is moving in the same direction.  
Providers also need a means for 
measuring and managing their 
processes to avoid losing control over 
their professional reputations and their 
reimbursement.  It is precisely this 
inability of a cottage industry to cope 
with measurement and management 
demands that will force providers 
to confront a choice: change or 
professionally “die” (ie, seek to earn 
some sort of living until retirement 
or simply retire immediately).
Some health care organizations 
have approached the “manage and 
measure” challenge by proactively 
posting their performance data online. 
Perhaps the foremost example of this 
trend is the decision by Louisville’s 
Norton Healthcare to post more 
than 200 specific clinical and patient 
satisfaction measures while providing 
an easy graphical comparison between 
Norton’s performance and national 
benchmarks for each measure.
While the zeitgeist of health care is 
shaped by economic and technological 
forces specific to the health care 
industry, it is also affected by events 
in the broader culture. Transparency 
and accountability are ascendant, 
whether in ratings of graduate schools 
or one-click access to your neighbor’s 
house price and real estate taxes. 
Meanwhile, a new generation of 
physicians is entering practice with 
different expectations than their 
elders about income, autonomy, and 
technology. Some have also emerged 
from training with a new understanding 
of “quality care” that looks beyond the 
“I know it when I see it” empiricism 
of the cottage industry model to the 
data-driven model of benchmarks 
related to both individual patients 
and to specific patient populations.
At first, the undermining of the old ways 
will bring uncertainty rather than utopia. 
Some quality improvement measures are 
applicable to hospitals, others to groups 
of physicians, and others to individual 
physicians.  It is not always obvious which 
measures can reliably be tied to which 
group. There will be arguments over 
who should be doing the measuring (eg, 
health plans, consumers, peers). And, for 
all the talk of “blame the system and not 
the individual,” no one expects regulators, 
accreditors, or attorneys to abandon the 
concept of individual accountability. 
Science historian Thomas Kuhn 
famously pointed out that the 
“traumatic” process of a “paradigm shift” 
does not occur until the defenders of the 
old ways “can no longer evade anomalies 
that subvert the existing tradition.” 
The evidence that the cottage industry 
model of medicine wastes money and 
kills and injures patients needlessly is 
decades old. But it is only because of 
powerful economic, technological, and 
cultural pressures that the traumatic 
process of change, uncomfortable yet 
irreversible, is finally under way.
Michael L. Millenson is a consultant, 
author, and the Mervin Shalowitz, 
MD Visiting Scholar at Northwestern 
University’s Kellogg School of 
Management. He can be reached at 
m-millenson@northwestern.edu.
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The major strategies of the national 
health policy to improve the performance 
of the American health system are to:
•	 Develop better tools to monitor  
 performance, 
•	 Increase transparency by making  
 performance information available  
 to purchasers and consumers, and 
•	 Develop appropriate incentives to
 drive performance improvement.
Medicare Quality Improvement 
Organizations (QIOs) are critical 
enablers for the implementation of 
these strategies on the national level. 
Created by an act of Congress in 
1982, every state has a QIO with the 
primary mission of improving health 
care for all Medicare beneficiaries.
Nursing Homes
In the fall of 2002, nursing homes 
became the first provider group to 
have mandatory reporting on a set 
of performance measures at the 
national level. QIOs were involved 
in publicizing the initial release of 
performance data and helping nursing 
homes learn the mechanics of proper 
data collection and submission. 
They also provide ongoing support 
to improve performance. A list 
of publicly reported nursing 
home performance measures and 
performance data for any nursing 
home can be viewed on the Nursing 
Home Compare Web site at www.
medicare.gov/NHCompare. Areas 
of national focus for improvement 
include high-risk pressure ulcers, 
rate of physical restraints, and 
incidence of chronic pain. 
Home Health Agencies
Reporting became mandatory for all 
home health agencies in the fall of 
2003. Current home health measures 
are available on Home Health Compare 
at www.medicare.gov/HHCompare.  
Again, QIOs facilitated national 
implementation of these measures 
and have provided ongoing assistance 
with performance improvement. A 
major area of focus has been to reduce 
the rate of acute care hospitalization 
among patients receiving home health 
services. QIOs in every state have been 
working with their state agencies to 
implement interventions for improved 
home monitoring, which allows for 
timely modifications to treatment 
plans, thus avoiding the need for acute 
care hospitalizations. 
Hospitals
A major breakthrough for hospital 
performance monitoring occurred in 
2002 when The Joint Commission 
and the Centers for Medicare and 
Medicaid Services (CMS) began to 
standardize their hospital performance 
measures. Hospitals accredited by 
The Joint Commission are required 
to submit self-collected performance 
data on a set of measures for acute 
myocardial infarction (AMI), 
congestive heart failure (CHF), 
and pneumonia. Standardization 
enabled transmission of the same 
data to a national QIO data 
warehouse.  Access to these data 
enabled QIOs to assist hospitals 
with planning QI interventions.  
The American Hospital 
Association teamed with other 
national stakeholders to create a 
hospital voluntary public reporting 
initiative that eventually became 
the Hospital Quality Alliance 
(HQA). Hospitals were asked to 
voluntarily report performance on 
a set of 10 measures: 5 for AMI, 
2 for CHF, and 3 for pneumonia. 
In the fall of 2004, HQA data 
became publicly available. 
Initially, QIOs were tasked with 
helping hospitals understand the 
mechanics of data submission. 
QIOs also were instrumental in 
recruiting hospitals to participate 
in this voluntary program. 
The program became somewhat 
less than voluntary with the passage 
of the Medicare Modernization 
Act of 2003 that required 
hospitals to report on this starter 
set of 10 measures in order to 
receive their full annual payment 
update. Almost overnight, all 
hospitals were participating. The 
requirements for reporting have 
now been expanded to include 21 
measures. Performance data on 
these measures can be viewed on 
the Hospital Compare Web site at 
www.hospitalcompare.hhs.gov.  
A recent change in hospital 
performance evaluation occurred 
with the creation of composite 
measures called Appropriate Care 
Measures (ACM). The initial 
composite measures gather data 
from the original 10 HQA measures. 
A hospital must obtain credit 
for having provided all care as 
measured by the 10 starter measures 
in order to be counted in the 
numerator for the ACM measures. 
QIOs have continued to work with 
hospitals throughout the process, 
providing technical assistance for 
improving internal care processes 
and thereby improving performance. 
This assistance has ranged from 
face-to-face visits at hospitals 
with one-on-one consultation, 
to facilitation of large, statewide 
hospital collaboratives that promote 
sharing of best practices. Steady
(continued on page 6)
The Role of Medicare 
Quality Improvement 
Organizations
By Donald F. Wilson, MD
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performance gains have occurred 
in the overall ACM measurements 
as well as the topic-specific ACMs 
for Pennsylvania and the nation. 
Physicians and Other
Individual Providers
A major barrier must be overcome 
for large-scale public reporting of 
performance measures to occur at the 
individual practitioner level.  Currently, 
the only mechanism that exists for 
collecting and reporting performance 
data at the individual provider level 
is administrative claims data.  These 
data have many significant limitations. 
Most experts agree that the only viable 
long-term solution is widespread 
adoption of electronic medical records 
(EMRs), followed by standardized 
electronic health information exchange 
(HIE). HIE will not only facilitate 
more efficient care, but will allow for 
provider-specific performance data to be 
collected and transmitted to appropriate 
warehouses for analysis and reporting. 
To help fuel the adoption of EMRs, 
QIOs have been involved in the 
national Doctor’s Office Quality – 
Information Technology (DOQ-IT) 
initiative for the past 3 years. Currently, 
QIOs are working with up to 5% of 
the primary care practitioners in each 
state to facilitate EMR adoption. 
Following EMR implementation, 
physician practices will be supported in 
using health information technology 
to provide better preventive care and 
improve care management for their 
patients with chronic diseases.  They 
will also be supported as they begin 
to transmit performance data directly 
from their EMRs into a national data 
warehouse for analysis and feedback. 
The Pennsylvania QIO is working 
with approximately 200 practices 
to implement and effectively use an 
EMR. We have developed a road 
map for tracking our progress with 
the practices. The goal is to get as 
many practices to the reporting 
stage as possible by the completion 
of the project in July 2008. Figure 
1 depicts our progress to date.
Value-Based Purchasing
As noted in the opening of this 
article, the last strategy to be 
implemented on a large scale will 
be the concept of value-based 
purchasing. Congress has directed 
CMS and other public programs to 
conduct pilot initiatives that will 
lead to broader implementation. 
Going forward, providers will 
receive differential payments for 
Medicare based, initially, on their 
reporting of quality measures 
and, eventually, on their actual 
performance on the measures. 
By passage of the Tax Relief and 
Health Care Act in December 
2006, Congress has already 
mandated implementation of 
the Physician Quality Reporting 
Initiative (PQRI), a pay-for-
reporting program for Medicare 
providers, effective July 2007. 
More information, and the list of 
included performance measures, 
can be viewed at www.cms.hhs.
gov/pqri. QIOs have been tasked 
with disseminating information 
about the initiative and encouraging 
providers to participate in this 
still voluntary effort. QIOs will 
undoubtedly be involved in the 
successful implementation of a 
hospital value-based purchasing 
initiative scheduled for launch 
sometime within the next year. 
This is an exciting time for 
health care in the United States. 
We have finally begun a long-
overdue transformation of our 
health care system. QIOs should 
be viewed as a precious national 
resource that works to keep us 
focused and moving forward.
Donald Wilson, MD, is Medical 
Director for Quality Insights of 
Pennsylvania. He can be reached 
at dowilson@wvmi.org.
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Leadership is widely recognized 
as a—if not the most—critical 
element in a successful patient 
safety program.  In cooperation 
with the National Patient Safety 
Foundation, the Health Research 
and Educational Trust launched 
the Patient Safety Leadership 
Fellowship in 2002 to help prepare 
the next generation of health care 
leaders to champion a culture 
of safety and make it a reality.  
Partners in this effort are the 
American Hospital Association, the 
American Organization of Nurse 
Executives, the American Society 
for Hospital Risk Managers, and 
the Society for Hospital Medicine.
Since 2002, more than 150 Fellows 
have graduated from this program.  
Fellows return to their organizations 
with the skills, models, and 
leadership capabilities needed to 
spearhead improvement projects, 
create culture change, and establish 
long-term strategic planning for 
safety in their organizations.
What Is the Patient Safety 
Leadership Fellowship?
The Patient Safety Leadership 
Fellowship is an intensive 12-
month learning experience that 
develops leadership competencies 
and advances patient safety science 
in health care through a dynamic, 
highly participatory, and structured 
learning community.  Fellows are 
exposed to a broad array of tools, 
strategies, and methodologies 
in the field of patient safety.  
The Fellowship brings together 
participants through leadership 
retreats, a meeting held in 
conjunction with the National 
Patient Safety Foundation 
Congress, and a virtual learning 
community in which Fellows 
learn from, and interact with, 
expert faculty. Everything in 
the Fellowship is designed to 
support Fellows’ implementation 
of important projects in their own 
organizations. A significant portion 
of the Fellowship curriculum 
focuses on how to engage others in 
their organizations both through 
their passion for patient safety and 
through their technical skills.
 
What Do the Fellows Learn?
The coursework includes self-
study modules and face-to-face 
meetings designed to support each 
Fellow’s Action Learning Project.  
The core curriculum covers 6 
major areas.  The first, what creates 
safe health care systems, explores 
what a safe organization looks 
like, as well as the epidemiology 
of patient safety.  The second 
area focuses on leadership, 
collaboration, and complexity and 
is designed to build skill sets for 
the innovation and adaptation 
necessary for advancing patient 
safety in a multidisciplinary 
environment.  Fellows learn the 
nature of complex change and 
how to use a systems approach 
to advance patient safety.  
The path to a culture of safety, 
the third module, explores the 
diverse subcultures within each 
health care organization, and 
identifies what can impede or 
enhance the development of a 
culture of high reliability and 
safety. The fourth module, lessons 
from inside and outside health care, 
addresses fundamental safety 
concerns, principles, and practices, 
focusing on industries where 
safety depends on coordinated 
team action and factors that 
influence human performance. 
The fifth module deals with 
disclosure, reporting, and 
transparency.  It teaches Fellows 
how to effectively report errors, 
how to disclose errors to patients 
and other key stakeholders, and 
how to promote transparency 
throughout the system.  The 
sixth and final module addresses 
the business case for creating 
cultures of safety, helping Fellows 
to understand and measure 
the relationship between 
safety, quality, and cost.
(continued on page 8)
“An unexpected outcome of the Fellowship was developing a community of 
experts to whom I can turn when faced with a patient safety challenge in 
my own organization. The support and advice provided by the other Fellows 
was—and continues to be—indispensable. The front line perspective of the 
Fellows provides ‘real world ’ balance to the theoretical, academic lessons of 
the program. When in the trenches, the support and advice of my Fellowship 
colleagues helps me navigate in my day-to-day work.”
— Kathy Leonhardt, MD, MPH, Associate Medical Director,
 Care Management, Aurora Health Care, Elm Grove, Wisconsin
The Patient Safety Leadership Fellowship:
Creating Change Agents
By Deborah Bohr, MPH
(continued from page 7)
Who Becomes A Fellow?
The Fellows are a diverse group of 
motivated and innovative health 
care leaders whose positions 
involve safety, quality, and 
risk: namely executive officers, 
medical officers, nurse executives, 
risk officers, physicians, nurse 
practitioners, infection control 
practitioners, pharmacy leaders, 
quality improvement leaders, and 
other health care professionals.  
Selection criteria for Fellows include 
prior training and experience and/
or demonstrated interest in working 
to develop and implement patient 
safety initiatives, and an Action 
Learning Project proposal that uses 
a collaborative, problem-solving 
approach for integrating patient 
safety initiatives at the applicant’s 
organization.  Preference is given 
to teams from the same institution.  
References from 2 peers with 
personal knowledge of an applicant’s 
leadership abilities and knowledge 
of patient safety science are required, 
along with a letter of support from 
senior leadership or the board of 
the applicant’s organization, which 
authorizes release time for the 
Fellowship and other support.
Action Learning Projects
Each Fellow or team has an Action 
Learning Project, which is the 
heart of the program. Each project 
focuses on advancing patient 
safety and health outcomes and 
is designed to address a priority 
of the Fellow’s organization.  
Fellows are asked to provide a 
midyear and final report to their 
organization’s executives and/
or board, in addition to their 
learning community of Fellows.
Over the past 5 years, the Fellows’ 
Action Learning Projects have 
clustered into 6 main categories: 
(1) error reporting/data collection 
systems, (2) the use of technology 
and medication administration, (3) 
improving clinical communication 
and coordination, (4) building 
organizational awareness and culture 
change, (5) building patient safety 
awareness through partnerships, and 
(6) staff training and development.
An example of an Action Learning 
Project is Improving Patient 
Safety Transitions ( Jane Foley, 
MHCA, Director of Operations, 
Cardiology/Critical Care; Kathleen 
P. Murray, Director, Process 
Improvement, Healthcare Quality; 
Gary B. Schweon, MSN, Director, 
Administration and Special 
Projects; and Julius Yang, MD, 
PhD, Medical Director.  Beth 
Israel Deaconess Medical Center, 
Boston, MA.)  This project team 
sought to promote process, system, 
culture, and technology change to 
ensure seamless, safe, and efficient 
passage for patients across the many 
transitions during their hospital 
experience (eg, from the intensive 
care unit or the operating room 
to a regular floor in the hospital). 
The project addressed improvement 
opportunities in key areas such 
as primary team responsibility, 
transfer of responsibility, sign-
out/handoff processes, and the 
care of “boarders” from one 
environment to another.  
Examples of other Action Learning 
Projects include Creating an 
Organizational Culture Supporting 
Patient Safety, Learning from 
Medical Errors, Training Medical 
Residents in Patient Safety, and 
Patient Safety and Toyota Work 
Principles. Select papers developed 
from these projects will be 
submitted for peer review and 
consideration of publication in 
a special Health Research and 
Educational Trust section of the 
American Journal of Medical Quality.
Fellowship Advisors and Faculty
A hallmark of the Fellowship is 
the personalized attention and 
mentoring by nationally recognized 
faculty and program advisors.  A 
list of the faculty can be seen on 
the Fellowship’s web page: http://
www.hret.org/hret/about/pslf.html.
Fellowship Alumni Association
The Fellowship is an ongoing 
journey rather than a onetime 
experience.  The Fellowship 
Alumni Association fosters 
lifelong connections and provides 
access to an influential network 
of health care leaders and safety 
researchers.  Fellows can continue 
their learning through active 
involvement, networking, and 
educational opportunities with 
the Alumni Association.
In summary, the goals of this 
Fellowship are to advance 
the theory and practice of 
transformational leadership in 
patient safety.  The program 
supports Fellows in learning how 
to take action in a framework that 
emphasizes innovation, understands 
complexity, builds personal mastery, 
and facilitates a change agenda 
within their organizations.  To 
achieve this mission-critical work, 
Patient Safety Leadership Fellows 
first explore what right things to 
do, and in doing those things right, 
ultimately transform health care.
Deborah Bohr, MPH is Director of 
Special Projects for the Health Research 
and Educational Trust of the American 
Hospital Association, Chicago, IL. She 
can be reached at dbohr@aha.org. 
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Last year, the Pennsylvania Health 
Care Cost Containment Council 
(PHC4) celebrated its 20th 
anniversary.  The road to public 
accountability has not always been easy, 
but the journey has been rewarding.  
Today, PHC4 is widely recognized as a 
national leader in public reporting and 
health care transparency, and it remains 
committed to providing Pennsylvanians 
with unparalleled access to health 
care information.  As PHC4 enters 
its third decade, it is venturing 
further into the next frontier of public 
reporting with an increased focus 
on payment data, readmissions, and 
hospital-acquired infections (HAIs).  
Although PHC4 has been collecting 
and reporting HAI data for less 
than 5 years, the value of making 
this information public is already 
apparent.  In addition to raising 
national awareness of HAI, a number 
of quality improvement initiatives 
have stemmed from these activities.  
This article provides an overview 
of PHC4’s most recent HAI report 
and discusses how data collection 
and reporting on such infections 
are spurring quality improvement. 
The First Hospital-Specific Report
In November 2006, PHC4 took an 
unprecedented step forward in the 
public reporting of HAIs. (Figure 1)
Previous PHC4 reports had focused 
on the aggregate quality-of-care 
and financial consequences of 
HAIs.  The latest report identified 
the actual number of infections 
reported by each of Pennsylvania’s 
168 individual hospitals for 2005, 
thereby establishing a baseline 
against which an individual hospital’s 
future performance can be measured.  
As the first state to release a 
hospital-specific report on HAIs, 
Pennsylvania raised the bar for other 
states and the nation as a whole. 
Statewide, the report presented 
the following highlights1: 
•	 Hospitals reported 19,154
 cases in which patients   
  contracted an HAI, a rate 
 of 12.2 per 1,000 cases. 
•	 The mortality rates for
 patients with and without 
 an HAI were 12.9% and 
 2.3%, respectively.  
•	 The average lengths of stay 
 for patients with and without 
 an HAI were 20.6 days and 
 4.5 days, respectively.  
•	 The average hospital charges 
 for patients with and without 
 an HAI were $185,260 and
 $31,389, respectively. (Table 1) 
•	 When looking at private sector 
 insurance reimbursements, 
 the average payments for a 
 case with and without an 
 HAI were $53,915 and $8,311, 
 respectively.
American Journal of Medical Quality 
(AJMQ) Supplement: 3 Pivotal Studies
PHC4’s public reporting 
on infections has sparked 
discussions among patients, 
policy makers, purchasers, and 
medical professionals.  Contrary 
to conventional wisdom, HAIs 
are not inevitable, unavoidable 
by-products of health care.  In 
fact, many can be prevented, a 
theme that was reinforced in the 
groundbreaking AJMQ supplement 
published a week after the release 
of PHC4’s hospital-specific report.  
The 3 studies contained in the 
supplement were unveiled during 
a press conference at the National 
Press Club in Washington, DC.  
All noted that HAIs are not about 
what the patient brings to the 
table; they are about improving 
hospitals’ processes of care.  
 
The first article described one 
hospital’s infection reduction 
efforts, demonstrating that the 
costs of treating an HAI can 
outstrip the payment system 
resulting in losses for the hospital, 
payors, and patients.2  The study 
is the explicit business case for 
eliminating these infections. 
Shannon et al found that although 
the average expense for a case 
with a central line-associated 
bloodstream (CLAB) infection
was $91,733, the average payment
(continued on page 10)
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Cases with a hospital-acquired infection $185,260 $53,915
Cases without a hospital-acquired infection $031,389 $08,311
Table 1. Report Findings: Cost Comparisons
(continued from page 9)
was $64,894 – an average loss of 
$26,839.2  Additionally, the study 
found that the patient’s severity 
of illness on admission was not a 
predictor of risk for developing a 
CLAB, but that dramatic reductions 
in the rates of CLABs could be 
achieved by standardizing processes 
of care and workflow redesign.  
The supplement’s other 2 studies 
confront and successfully challenge 
the issue of “blaming” patient 
characteristics (ie, age, risk factors, 
severity of illness) for the cost 
and quality impact of higher 
infection rates.3,4  Both of these 
articles reported on analyses of  
HAI data collected by PHC4.
Peng et al examined differences in 
mortality, length of stay, and hospital 
charges between hospitalizations with 
and without an HAI.3  They found 
that differences in these measures 
cannot be explained on the basis of 
how sick the patient was at admission. 
The third study, by Hollenbeak 
et al, used statewide data 
collected on surgical wound 
infections to estimate the impact 
of patient-specific factors on 
the risk of infection.4  Although 
patient-specific factors had a 
significant association with risk 
of infection, much of the risk was 
determined by hospital factors.
Demonstration Projects 
The collection and reporting of data 
are necessary first steps in reducing 
HAIs; however, the ultimate goal 
is to provide infection-control 
practitioners with tools to identify 
areas of improvement.  For this 
reason, PHC4 has collaborated 
on 2 major initiatives that 
emphasize infection reduction.
In 2005, PHC4 collaborated with 
the Jewish Healthcare Foundation 
in awarding grants to 5 hospitals 
for demonstration projects to 
quantify the costs and reduce the 
number of HAIs.  The hospitals 
were challenged to duplicate the 
groundbreaking work pioneered by 
Shannon and staff at Pittsburgh’s 
Allegheny General Hospital (ie, to 
reduce to near zero the number of 
infections in critical care units).
Although the 5 hospitals focused 
on different aspects of infection 
reduction, the results across the board 
were impressive, with each hospital 
reporting a decrease in infections.  
Notably, payment issues were 
somewhat less clear; some hospitals 
suffered financial losses on infection 
cases while others did not lose 
money.  The consensus was that any 
determination about the economics of 
infection reduction depends somewhat 
on how hospital costs are allocated.  
Ultimately, the work by the hospitals 
demonstrated that more study is 
needed, particularly around hospitals’ 
disparate cost accounting methods.  
Each of the 5 hospitals reported that 
their awareness of issues relating 
to infections was significantly 
increased due to this project.  The 
work also served as a springboard 
for other infection reduction 
strategies, and demonstrated 
what can be accomplished when 
organizations strive for perfection 
rather than unquestioningly 
accepting standard benchmarks.
In 2006, PHC4 launched a second 
pilot project aimed at infection 
reduction.  PHC4 and the Highmark 
Foundation awarded grants to 
10 Pennsylvania hospitals and 
1 health system to implement 
new technology for tracking and 
proactively preventing HAIs.  The 
hospitals selected for the Reducing 
Hospital-Acquired Infections with 
Electronic Surveillance Demonstration 
Project received funding to assist 
in their utilization of an electronic 
surveillance system that removes 
subjectivity from identification and 
reporting of infections.  Although it 
is too early for results, the hospitals 
using this technology have said it frees 
infection-control staff from labor- 
intensive manual collection so they 
can spend more time actually finding 
and preventing the causes of HAIs.
The Positive Impact of Public Reporting 
Even though public reporting of the 
incidence of HAIs has just begun, 
there is evidence that such reporting of 
health care outcomes improves quality.  
Two examples from the literature 
highlight the benefits of publicly 
reporting hospital performance.  Dr. 
Judith Hibbard and colleagues (from 
the University of Oregon) found that 
Wisconsin hospitals that publicly 
reported hospital performance 
were significantly more likely to 
increase their quality improvement 
activities than 2 comparison groups 
that reported privately or not at 
all.5 In addition, researchers
(continued on page 11)
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found that, while coronary artery 
bypass graft surgery mortality 
rates have dropped nationally, they 
have dropped more significantly 
in states with public reporting 
(eg, Pennsylvania, New York).6 
As the issue of HAIs has come to the 
forefront of patient safety, important 
quality improvement efforts are being 
instituted.  The Institute for Health 
Improvement’s 100,000 Lives Campaign 
(now the 5 Million Lives Campaign) has 
provided many success stories among 
hospitals.  Medicare has indicated 
that it will stop paying hospitals for 
expenses related to HAIs in 2008, and 
more states are passing laws that require 
public reporting of infection rates.  
By continuing its history of public 
reporting, PHC4 hopes to spur 
additional quality improvement 
initiatives and further contribute to 
the ongoing national conversation 
about HAIs.
Flossie Wolf, MS is the Director of Health 
Policy Research at the Pennsylvania 
Health Care Cost Containment Council.  
She can be reached at fwolf@phc4.org. 
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Web Sites of Interest
Agency for Healthcare Research and Quality
Quality and Patient Safety
  www.ahrq.gov/qual/
Medical Errors and Patient Safety
  www.ahrq.gov/qual/errorsix.htm
AQA Alliance
Organization dedicated to both ambulatory and hospital quality
  www.aqaalliance.org/
Centers for Medicare and Medicaid Services (CMS)
Hospital Quality Alliance 10 Measure “Starter Set”
  www.cms.hhs.gov/HospitalQualityInits/downloads/HospitalStarterSet200512.pdf
CMS/Premier Hospital Quality Incentive Demonstration (HQID)
Government/industry partnership demonstration project to improve quality and safety
  www.premierinc.com/quality-safety/tools-services/p4p/hqi/index.jsp
Health Research Education Trust
General information
  www.hret.org/hret/about/
Institute for Healthcare Improvement
General Information about the organization
  www.ihi.org/ihi/about
Institute of Medicine
Access to two seminal reports, Crossing the Quality Chasm and To Err is Human 
  www.iom.edu/CMS/8089.aspx
The Chasm in Quality: Select Indicators from Recent Reports
  www.iom.edu/CMS/8089/14980.aspx
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Upcoming Issues
Look for the following articles in future issues of Prescriptions for Excellence in Health Care
   Quality and Safety by Design – Creating a hospital building environment designed to reduce error and
 improve patient safety
   Ambulatory Quality Measurement: The Jefferson University Physicians Experience – 
 Developing a system-wide approach to ambulatory quality improvement
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